Association of ethnicity, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis

Journal of the American Academy of Dermatology

Volumn 69, Issue 1, 2013, Pages 167-168

  Wu, Jashin J ^a   Poon, Kwun Yee T ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR;

CAUCASIAN; COHORT ANALYSIS; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNICITY; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TOPICAL TREATMENT;

EID: 84879121099     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.02.019     Document Type: Article

References (2)

1. J. Channual, J.J. Wu, and F.J. Dann Effects of TNF-alpha blockade on metabolic syndrome in psoriasis: lessons learned from rheumatoid arthritis and psoriatic arthritis Dermatol Ther 22 2009 61 73
2. J.J. Wu, K.T. Poon, J.C. Channual, and A.Y. Shen Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis Arch Dermatol 148 2012 1244 1250